Regresar

Foto de Broderick J.P.

Broderick J.P.

268

Coauthors

8

Documentos

Volumen de publicaciones por año

Cargando gráfico

Año de publicación	Num. Publicaciones
2015	1
2017	2
2018	1
2019	2
2021	1
2022	1

Publicaciones por áreas de conocimiento

Cargando gráfico

Área de conocimiento	Num. Publicaciones
Medicina interna	7
Neurología	5
Medicamento	5
Trazado	3

Publicaciones por áreas temáticas

Cargando gráfico

Área temática	Num. Publicaciones
Enfermedades	6
Medicina y salud	3
Farmacología y terapéutica	3
Fisiología humana	3
Ginecología, obstetricia, pediatría, geriatría	3
Contabilidad	1
Problemas sociales y servicios a grupos	1
Medicina forense; incidencia de enfermedades	1
Salud y seguridad personal	1

Principales fuentes de datos

Origen	Num. Publicaciones
Scopus	8
Google Scholar	0
RRAAE	0

Cargando gráfico

Coautores destacados por número de publicaciones

Coautor	Num. Publicaciones
Martins S.O.	9
Bath P.M.W.	8
Lavados P.M.	8
Octavio Marques Pontes-Neto	8
Ricci S.	8
Robinson T.G.	8
Wang J.G.	8
Sharma V.K.	8
Chalmers J.	8
Woodward M.	8

Cargando gráfico

Top Keywords

Cargando gráfico

Publicaciones del autor

Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke inthe ENCHANTEDtrial

Abstract: Objective: Limited data exist on the optimum level of SBP in thrombolyzed patients with acute ischem

Palabras claves:

Hypertension, Ischemic stroke, large vessel occlusion, recanalization, thrombolysis, Trial

Anderson C.S., Bath P.M.W., Broderick J.P., Chalmers J., Delcourt C., Demchuk A.M., Durham A.C., Kim J.S., Lavados P.M., Lee T.H., Lindley R.I., Martins S.O., Minhas J.S., Octavio Marques Pontes-Neto, Ricci S., Robinson T.G., Sharma V.K., Song L., Wang J.G., Wang X., Woodward M.

Lipid-lowering pretreatment and outcome following intravenous thrombolysis for acute ischaemic stroke: a post hoc analysis of the enhanced control of hypertension and thrombolysis stroke study trial

Abstract: Background: Debate exists as to whether statin pretreatment confers an increased risk of 90-day mort

Palabras claves:

Acute stroke outcome, Intracranial haemorrhage, Lipid-lowering therapy, OR, RISK FACTORS, statins, stroke

Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Martins S.O., Minhas J.S., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Ricci S., Robinson T.G., S Anderson C., Sato S., Sharma V.K., Thang N.H., Wang J.G., Wang X., Woodward M.

Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry

Abstract: Background: Randomized controlled trials provide high-level evidence, but the necessity to include s

Palabras claves:

acute ischemic stroke, Alteplase, Clinical trial, health outcomes, thrombolysis

Arima H., Bath P.M.W., Bray B.D., Broderick J.P., Chalmers J., Durham A.C., Kim J.S., Lavados P.M., Lee T.H., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Paley L., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., Rudd A.G., S Anderson C., Sharma V.K., Sprigg N., Wang J.G., Wang X., Woodward M.

Low-Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy the ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study)

Conference Object

Abstract: Background and Purpose'Many patients receiving thrombolysis for acute ischemic stroke are on prior a

Palabras claves:

aspirin, Brain Infarction, Hypertension, intracranial hemorrhages, Tissue plasminogen activator

Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Demchuk A.M., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Lindley R.I., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sato S., Sharma V.K., Wang J.G., Wang X., Woodward M.

Low-dose vs standard-dose alteplase for patients with acute ischemic stroke: Secondary analysis of the ENCHANTED randomized clinical trial

Abstract: IMPORTANCE: A lower dose of intravenous alteplase appears to be a safer treatment option than the st

Palabras claves:

Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Demchuk A.M., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Li Q., Lindley R.I., Martins S.O., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sharma V.K., Thang N.H., Wang J.G., Wang X., Woodward M.